Hormone replacement therapy [topp]
Health [idcn]
postmenopausal [tmco]
Women [popg]
randomized [resa]
placebo controlled study [inpr, resa]
effects [qlco]
Coagulation [ortf]
fibrinolytic [topp]
objectives [inpr]
Evaluate [ftcn]
effects [qlco]
Hormone Replacement Therapy, Post-Menopausal [topp]
von Willebrand Factor [aapp, bacs, phsu]
Factor VIII [aapp, bacs, phsu]
Factor VII [aapp, bacs, phsu]
Fibrinogen [aapp, bacs, phsu]
Antithrombin III [aapp, phsu]
Prothrombin [aapp, bacs, phsu]
fragment [ftcn]
Protein C [aapp, bacs, phsu]
Free protein S [aapp, bacs]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Resistance [menp]
Activated protein C [aapp, enzy]
Design [acty]
Part [spco]
DOUBLE BLIND [resa]
randomized [resa]
Trial [resa]
3 Months [tmco]
Part [spco]
Open [spco]
Study [mnob]
months [tmco]
setting [ftcn]
Department [orgt]
Endocrinology [bmod]
university hospital [hcro, mnob]
Sweden [geoa]
Subject [grup]
postmenopausal [tmco]
Women [popg]
History [ocdi]
Amenorrhea [dsyn]
months [tmco]
Body Mass Index [diap]
Equal [qlco]
kg-m [qnco]
Part [spco]
Part [spco]
intervention [hlca]
Randomization [resa]
placebo [topp]
N NOS [aapp, imft]
Hormone replacement therapy [topp]
N NOS [aapp, imft]
Hormone replacement therapy [topp]
GIVEN [cnce]
mg% [qnco]
Oestradiol valerate [horm, phsu, strd]
months [tmco]
Addition [ftcn]
mg% [qnco]
Medroxyprogesterone [horm, phsu, strd]
10 days [tmco]
measurements [ftcn]
baseline [bodm]
months [tmco]
months [tmco]
Hormone replacement therapy [topp]
Group [idcn]
Increased [qnco]
P NOS [aapp, imft]
Fibrinogen [aapp, bacs, phsu]
Antithrombin III [aapp, phsu]
Protein S [aapp, bacs]
Decreased [qnco]
P NOS [aapp, imft]
variables [qlco]
Delta [inpr]
Values [qlco]
3 Months [tmco]
Delta [inpr]
Values [qlco]
Group [idcn]
Fibrinogen [aapp, bacs, phsu]
P NOS [aapp, imft]
Antithrombin III [aapp, phsu]
P NOS [aapp, imft]
Total protein [lbpr]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
P NOS [aapp, imft]
months [tmco]
Fibrinogen [aapp, bacs, phsu]
Protein S [aapp, bacs]
Tissue Plasminogen Activator [aapp, enzy, phsu]
P NOS [aapp, imft]
Antithrombin III [aapp, phsu]
P NOS [aapp, imft]
Decreased [qnco]
Control Group [grup]
variables [qlco]
Unchanged [fndg]
Study [mnob]
increases [ftcn]
P NOS [aapp, imft]
Protein S [aapp, bacs]
months [tmco]
Decrease [qlco]
P NOS [aapp, imft]
months [tmco]
months [tmco]
Delta [inpr]
Values [qlco]
Fibrinogen [aapp, bacs, phsu]
P NOS [aapp, imft]
Antithrombin III [aapp, phsu]
P NOS [aapp, imft]
Total protein [lbpr]
Conclusions [idcn]
Estrogen [horm, phsu, strd]
Substitution [idcn]
effects [qlco]
decreases [qnco]
Fibrinogen [aapp, bacs, phsu]
effects [qlco]
Decreasing [qlco]
Antithrombin III [aapp, phsu]
Protein S [aapp, bacs]
Increasing [ftcn]
Prolonged [tmco]
Addition [ftcn]
Progesterone [horm, phsu, strd]
Group [idcn]
Concern [idcn]
Attenuated [qlco]
Suggest [idcn]
effects [qlco]
Hormone replacement therapy [topp]
Coagulation [ortf]
Institution [hcro, mnob]
treatment [ftcn]
